Novartis Beats PTAB Challenge To MS Drug Patent
The Patent Trial and Appeal Board has upheld a Novartis patent covering Gilenya, a multiple sclerosis treatment, that had been challenged by several generic-drug companies....To view the full article, register now.
Already a subscriber? Click here to view full article